Interleukin-23 Antagonist drugs
17 medications in the FDA established pharmacologic class “Interleukin-23 Antagonist”.
| Drug | Type | NDC products |
|---|---|---|
| Skyrizi Risankizumab-rzaa | Rx | 10 |
| Omvoh Mirikizumab-mrkz | Rx | 7 |
| Wezlana Ustekinumab-auub | Rx | 7 |
| Pyzchiva Ustekinumab-ttwe | Rx | 5 |
| Yesintek Ustekinumab | Rx | 4 |
| Otulfi Ustekinumab-aauz | Rx | 4 |
| Selarsdi Ustekinumab-aekn | Rx | 4 |
| Starjemza Ustekinumab-hmny | Rx | 4 |
| Steqeyma Ustekinumab-stba | Rx | 4 |
| Ustekinumab-ttwe | Rx | 4 |
| Ustekinumab-aekn | Rx | 4 |
| Stelara Ustekinumab | Rx | 3 |
| Ustekinumab | Rx | 3 |
| Tremfya Guselkumab | Rx | 3 |
| Imuldosa Ustekinumab-srlf | Rx | 3 |
| Ustekinumab-aauz | Rx | 2 |
| Ilumya Tildrakizumab-asmn | Rx | 1 |